BioPharm International
CONTINUE TO SITE >

OR WAIT 15 SECS

Siddharth J. Advant, PhD

King of Prussia

Pennsylvania

Articles

The Company at the Crossroads. Part 2: Build or Buy?

When making critical decisions such as whether to build or buy critical capabilities, companies need a decision-making approach that weighs risks and rewards as a science with adequate inputs, repeatable processes, and measurable results. The method must also accommodate the human factor by encouraging wide participation and providing the kind of neutral decision criteria that satisfies participants about the objectivity of the process.

The Company at the Crossroads. Part 1: To Commercialize or Not?

Every biotech company reaches a point in its development where it must decide what path it will take after it passes the start-up phase. This article discusses what the company must consider to decide what business model it will follow.